and/or

109 News Items found

In the Lab

Special Delivery: Nano-Size Particles Carry Personalized Medicines to Cancer’s Doorstep

Using computer intelligence, scientists are building drug-loaded nanoparticles that deliver a knockout blow to cancer.

MSK chemist Daniel Heller with models of his nanoparticles

In the Clinic

Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

For adults with chemotherapy-resistant leukemia, CAR T cell therapy can be a lifesaving treatment option. New results suggest how to make it safer.

Medical oncologist Jae Park

In the Lab

Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer

The online resource will serve as a benchmark for researchers studying metabolism and cancer.

abstract red and blue lines suggestive of metabolic pathways

In the Lab

Deciphering How Membrane Enzymes Work, with a Little Help from Beetles

The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.

A gray blob marked RAS linked to colorful rods marked ICMT

In the Lab

Prostate Cancer Drug Could Protect Bone Marrow from Damage Caused by Radiation

Researchers are working on a novel method for addressing a common complication of cancer treatment — bone marrow suppression.

Cross sections of mouse femurs showing bone marrow after radiation and no drug (left) and after radiation plus drug (right).

In the News

Year in Review: The Science and Technology that Shaped Cancer Care in 2017

As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.

Gears with 2016 and 2017

In the Lab

When Cancer Spreads: Research Focuses on Better Ways to Treat Metastasis

MSK investigators are learning how cancer cells escape from the original tumor and hide out in the body. Their goal is to prevent metastatic tumors from forming.

Sloan Kettering Institute Director Joan Massagué with laboratory member Karuna Ganesh

In the Lab

With Help of CRISPR, Scientists Unravel the Cause of a Rare Liver Cancer

A team led by MSK molecular biologist Scott Lowe is making progress against fibrolamellar hepatocellular carcinoma.

A microscopic view of genetically engineered mouse tumor and a human FL-HCC tumor

Science Byte

PSMA: A New Target for Prostate Cancer Treatment

Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.

Prostate cancer cells, colored red in scanning electron micrograph (SEM).

In the Lab

MSK-Developed Technology Provides a “Virtual Biopsy” of Immune Cells in Tumors

The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.

iron-filled macrophages from a breast cancer tumor